CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-16 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −1,611 | $60.21 | $97K | 208,631 |
| 2018-04-16 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −115 | $60.21 | $7K | 69,333 |
| 2018-04-07 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −144 | $57.06 | $8K | 69,448 |
| 2018-04-07 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −2,014 | $57.06 | $115K | 210,242 |
| 2018-04-07 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −391 | $57.06 | $22K | 20,001 |
| 2018-04-06 | Marken James G. SVP Ops & Prod Dev | Grant or award | +4,400 | 69,592 | ||
| 2018-04-06 | Marken James G. SVP Ops & Prod Dev | Grant or award · Stock Options | +5,300 | 5,300 | ||
| 2018-04-06 | CAREY STEPHEN P. Vice President and CFO | Grant or award | +8,000 | 14,118 | ||
| 2018-04-06 | CAREY STEPHEN P. Vice President and CFO | Grant or award · Stock Options | +9,600 | 9,600 | ||
| 2018-04-06 | PRZYBYL ARTHUR President and CEO | Grant or award | +29,100 | 212,256 | ||
| 2018-04-06 | PRZYBYL ARTHUR President and CEO | Grant or award · Stock Options | +35,200 | 35,200 | ||
| 2018-04-06 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Grant or award | +8,000 | 20,392 | ||
| 2018-04-06 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Grant or award · Stock Options | +9,600 | 9,600 | ||
| 2018-03-31 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −546 | $58.22 | $32K | 12,392 |
| 2018-03-31 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −2,550 | $58.22 | $148K | 183,156 |
| 2018-03-31 | CAREY STEPHEN P. Vice President and CFO | Shares withheld for taxes | −507 | $58.22 | $30K | 6,118 |
| 2018-03-31 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −278 | $58.22 | $16K | 65,192 |
| 2018-03-20 | HOLUBOW FRED Director | Exercise or conversion | +2,000 | 14,811 | ||
| 2018-03-20 | HOLUBOW FRED Director | Exercise or conversion · Stock Options | +2,000 | 1,333 | ||
| 2018-03-19 | RAYNOR DANIEL Director | Sale | −5,313 | $60.62 | $322K | 289,003 |
Page 32 of 41 · 804 trades